APOE and Alzheimer disease: When considering all AD patients independently from neuropathological alterations, the risk allele of rs1990622 conferred increased susceptibility to late-onset AD only in the apolipoprotein E (APOE) ε4 allele carriers [45], with no impact on cognitive deterioration progression [33].